Ionis Pharmaceuticals (IONS) PT Lowered to $54 at BMO Capital Post Pelacarsen Failure

September 8, 2026 7:26 AM

(Updated - September 8, 2026 9:24 AM EDT)

BMO Capital analyst David Lebowitz lowered the price target on Ionis ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found